Back to Search
ANNE PALUMBO, DO
DO
Infectious Disease Physician
NPI: 1396731709Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
3368(IA)036101964(IL)OS008197L(PA)
Research & Publications (20)
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results.
PMID 19406725·Clin Lymphoma Myeloma·2009
3-trial
Reduction of vitellogenin synthesis by an aryl hydrocarbon receptor agonist in the white sturgeon (Acipenser transmontamus).
PMID 19292566·Environ Toxicol Chem·2009
7-preclinical
Optimization and validation of a California halibut environmental estrogen bioassay using a heterologous ELISA.
PMID 19004476·Sci Total Environ·2009
4-observational
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
PMID 19494840·Leukemia·2009
6-review
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.
PMID 18774632·Blood Rev·2009
6-review
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
PMID 18094721·Leukemia·2008
6-review
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.
PMID 18505783·Blood·2008
2-rct
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma.
PMID 18326520·Ann Oncol·2008
3-trial
Update on recent developments for patients with newly diagnosed multiple myeloma.
PMID 18837878·Ann N Y Acad Sci·2008
3-trial
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma.
PMID 17148584·Blood·2007
3-trial
Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
PMID 17785703·J Clin Oncol·2007
3-trial
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
PMID 17594696·Cancer·2007
8-other
Induction and partial characterization of California halibut (Paralichthys californicus) vitellogenin.
PMID 17188011·Comp Biochem Physiol A Mol Integr Physiol·2007
7-preclinical
Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma.
PMID 16796778·Clin Lymphoma Myeloma·2006
3-trial
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
PMID 16530576·Lancet·2006
4-observational
Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
PMID 16519697·Eur J Haematol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 913 NW GARDEN VALLY BLVD, ROSEBURG VA HEALTHCARE SYSTEM
ROSEBURG, OR 97471 - Phone
- (541) 440-1377
Quick Facts
- NPI
- 1396731709
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile